Summary
The records of thirty-four patients with meningeal carcinomatosis treated at our hospital between 1984 and 1990 were reviewed. The sources, histologies, metastatic lesions outside the central nervous system, the history of the treatment of primary lesions and intraparenchymal of metastatic brain tumors and the period from the diagnosis of primary lesions and the treatment of intraparenchymal metastatic brain tumors to the diagnosis of meningeal carcinomatosis were investigated. Meningeal carcinomatosis was diagnosed and by neurological signs, CSF cytology, CT scan and MRI.
Each patient was given a 5 mg single dose of methotrexate (MTX) alone or combined with 20 mg cytosine arabinoside (Ara-C) adminstered by intrathecal injection via an Ommaya reservoir and standard lumbar puncture with or without radiotherapy. Following intrathecal chemotherapy 22 of 29 patients showed symptomatic improvement of meningeal irritation and in 10 of 29 patients with cranial nerve impairment amelioration of symptoms was also observed. Moreover, CSF cytology became negative in 10 of 29 patients after a full course of intrathecal chemotherapy. Neurotoxicity Leukoencephalopathy, a neurotoxic effect of intrathecal chemotherapy was not observed in any of the patients. From these results, MTX in small doses is recommended for intrathecal chemotherapy of meningeal carcinomatosis to prevent neurotoxicity.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Olson ME, Chernik NL, Posner JB: Infiltration of the leptomeninges by systemic cancer: A clinical pathological study. Arch Neurol 30: 122–137, 1974
Shapiro WR, Posner JB, Ushio Y, Chernik NL, Young DF: Treatment of meningeal neoplasms. Cancer Treat Rep 61: 733–743,1977
Wasserstrom WR, Glass JP, Posner JB: Diagnosis and treatment of leptomeningeal metastases from solid tumors. Experience with 90 patients. Cancer 49: 759–772, 1982
Yap HY, Yap BS, Tashima CK, DiStefano A, Blumenschein GR: Meningeal carcinomatosis in breast cancer. Cancer 42: 283–286, 1978
Gonzalez-Vitale JC, Garcia-Bunuel R: Meningeal carcinomatosis. Cancer 37: 2906–2911, 1976
Sorensen SC, Eagan RT, Scott M: Meningeal carcinomatosis in patients with primary breast or lung cancer. Mayo Clin Proc 59: 91–94, 1984
Turner DM, Graf CJ: Nontraumatic subdural hematoma secondary to dural metastasis: Case report and review of the literature. Neurosurgery 11: 678–680, 1982
Little JR, Dale AJD, Okazaki H: Meningeal carcinomatosis. Clinical manifestations. Arch Neurol 30: 138–143, 1974
Theodore WH, Gendelman S: Meningeal carcinomatosis. Arch Neurol 38: 696–699, 1981
Fischer-Williams M, Bosanquet FD, Daniel PM: Carcinomatosis of the meninges: A report of three cases. Brain 78: 42–58, 1955
Heathfield KWG, Williams JRB: Carcinomatosis of the meninges: Some clinical and pathological aspects. Br Med J 1:328–330,1956
Ongerboer de Visser BW, Somers R, Nooyen WH, Van Heerde P, Hart AAM, McVie JG: Intraventricular methotrexate therapy of leptomeningeal metastasis from breast carcinoma. Neurology 33: 1565–1572, 1983
Pedersen AG, Paulson OB, Gyldensted C: Metrizamide myelography in patients with small cell carcinoma of the lung suspected of meningeal carcinomatosis. J Neuro Oncol 3: 85–89, 1985
Krol G, Sze G, Malkin M, Walker R: MR of cranial and spinal meningeal carcinomatosis: Comparison with CT and myelography. AJR 151: 583–588, 1988
Davis PC, Friedman NC, Fry SM, Malko JA, Hoffmann JC Jr, Braun IF: Leptomeningeal metastasis: MR imaging. Radiology 163: 449–454, 1987
Sze G, Soletsky S, Bronen R, Krol G: Mr imaging of the cranial meninges with emphasis on contrast enhancement and meningeal carcinomatosis. AJNR 10: 965–975, 1989
Rodesch G, Bogaert PV, Mavyoudakis N, Parizel PM, Martin JJ, Segebarth C, Vyve MV, Baleriaux D, Hildebrand J: Neuroradiologic findings in leptomeningeal carcinomatosis: the value interest of gadolinium-enhanced MRI. Neuroradiology 32: 26–32, 1990
Yousem DM, Patrone PM, Grossman RI: Leptomeningeal metastases: MR evaluation. J Comput Assist Tomogr 14: 255–261,1990
Shapiro WR, Young DF, Mehta BM: Methotrexate distribution in cerebrospinal fluid after intravenous, ventricular and lumbar injection. N Eng J Med 293: 161–166, 1975
Bleyer WA, Poplack DG: Intraventricular versus intralumbar methotrexate for central-nervous-system leukemia: Prolonged remission with the Ommaya reservoir. Med Ped Oncol 6: 207–213, 1979
Murray JJ, Greco FA, Wolff SN, Hainsworth JD: Neoplastic meningitis. Marked variations of cerebrospinal fluid composition in the absence of extradural block. Am J Med 75:289–294,1983
Hitchins RN, Bell DR, Woods RL, Levi JA: A prospective randomized trial of single-agent versus combination chemotherapy in meningeal carcinomatosis. J Clin Oncol 5: 1655–1662,1987
Giannone L, Greco FA, Hainsworth JD: Combination intraventricular chemotherapy for meningeal neoplasia. J Clin Oncol 4: 68–73, 1986
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Nakagawa, H., Murasawa, A., Kubo, S. et al. Diagnosis and treatment of patients with meningeal carcinomatosis. J Neuro-Oncol 13, 81–89 (1992). https://doi.org/10.1007/BF00172949
Issue Date:
DOI: https://doi.org/10.1007/BF00172949